![]() |
市场调查报告书
商品编码
1305164
全球体液采集和诊断市场研究报告 - 行业分析、规模、份额、增长、趋势及2023至2030年预测Global Body Fluid Collection And Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030 |
据预测,全球体液采集与诊断市场需求将从2022年的334.1亿美元增至2030年的696.6亿美元,2023-2030年的复合年增长率为9.62%。
体液采集和诊断是指采集、分析和检测体内各种液体,如血液、尿液、唾液和脑脊液。进行这些检测是为了诊断和监测各种病症,包括传染病、癌症、代谢紊乱和荷尔蒙失调。体液采集和诊断涉及多个步骤,包括采集样本、准备分析样本和使用各种诊断技术分析样本。体液采集可通过各种方法进行,包括静脉穿刺、尿液采集和唾液采集。样本采集完成后,将在实验室进行处理并使用一系列诊断方法进行分析,如显微镜检查、培养和分子诊断。这些检查可提供有关体内是否存在特定物质的信息,如蛋白质、激素和酶,以及是否存在异常细胞或微生物。体液采集和诊断检测的结果可用于诊断病情、监测疾病进展和评估治疗效果。这些检测是现代医疗实践的重要组成部分,在疾病预防和管理方面发挥着重要作用。
需要定期进行体液检测的慢性疾病发病率不断上升,推动了对体液采集和诊断技术的需求。液体活检和新一代测序等先进诊断技术的发展提高了体液采集和诊断的准确性和效率。患者和医疗服务提供者对微创手术的采用推动了对微创体液采集方法的需求。人们对早期疾病检测重要性的认识不断提高,这推动了对体液采集和诊断技术的需求,因为这些检测有助于在疾病更易治疗的早期阶段发现疾病。许多国家政府正在实施促进早期疾病检测和改善医疗设施的倡议,这推动了体液采集与诊断市场的增长。远程医疗和虚拟会诊已变得越来越普遍,使个人更容易在家中获得体液采集和诊断服务。
研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰了解行业结构,评估全球竞争吸引力。此外,这些工具还对全球体液采集与诊断市场的各个细分市场进行了全面评估。体液采集与诊断行业的增长和趋势为本研究提供了整体方法。
体液采集与诊断市场报告的这一部分提供了国家和地区层面细分市场的详细数据,从而帮助战略家确定各自产品或服务的目标人群以及即将到来的机会。
本节涵盖区域前景,重点介绍北美、欧洲、亚太、拉美以及中东和非洲地区体液采集与诊断市场的当前和未来需求。此外,报告还重点关注了所有主要地区各个应用领域的需求、估计和预测。
该研究报告还涵盖了市场主要参与者的综合概况以及全球竞争格局的深入分析。体液采集和诊断市场的主要参与者包括赛默飞世尔科技公司、Bio-Rad实验室、Illumina公司、Guardant Health、QIAGEN、强生公司、美国实验室公司控股、Biocept公司、F. Hoffmann-La Roche Ltd.、MDxHealth SA。本节包括竞争格局的整体视图,其中包括各种战略发展,如关键并购、未来能力、合作伙伴关系、财务概况、合作、新产品开发、新产品上市和其他发展。
*注:在公司概况中,财务细节和近期发展取决于可用性,如果是私营公司,则可能不包括在内。
The global demand for Body Fluid Collection And Diagnostics Market is presumed to reach the market size of nearly USD 69.66 BN by 2030 from USD 33.41 BN in 2022 with a CAGR of 9.62% under the study period 2023 - 2030.
Body fluid collection and diagnostics refer to the collection, analysis, and testing of various fluids within the body, such as blood, urine, saliva, and cerebrospinal fluid. These tests are performed to diagnose and monitor various medical conditions, including infectious diseases, cancer, metabolic disorders, and hormonal imbalances. Body fluid collection and diagnostics involve several steps, including the collection of the sample, preparation of the sample for analysis, and analysis of the sample using various diagnostic techniques. The collection of body fluids can be done through various methods, including venipuncture, urine collection, and saliva collection. Once the sample has been collected, it is processed and analyzed in a laboratory using a range of diagnostic methods, such as microscopy, culture, and molecular diagnostics. These tests can provide information related to the presence of specific substances in the body, such as proteins, hormones, and enzymes, as well as the presence of abnormal cells or microorganisms. The results of body fluid collection and diagnostics tests can be used to diagnose medical conditions, monitor the progression of any disease, and evaluate the effectiveness of treatments. These tests are an essential part of modern medical practice and play a vital role in disease prevention and management.
The increasing incidence of chronic diseases which require regular body fluid testing, is driving the demand for body fluid collection and diagnostics. The development of advanced diagnostic techniques and technologies, such as liquid biopsy and next-generation sequencing, has improved the accuracy and efficiency of body fluid collection and diagnostics. The adoption of minimally invasive procedures among patients and healthcare providers is driving the demand for less invasive body fluid collection methods. The awareness about the importance of early disease detection is scaling up, which is driving the demand for body fluid collection and diagnostics, as these tests can help detect diseases at an early stage when they are more treatable. Many governments are implementing initiatives to promote early disease detection and improve healthcare facilities, which is driving the growth of the body fluid collection and diagnostics market. Telemedicine and virtual consultations have become more prevalent, making it easier for individuals to access body fluid collection and diagnostic services from the comfort of their homes.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of body fluid collection and diagnostics. The growth and trends of body fluid collection and diagnostics industry provide a holistic approach to this study.
This section of the body fluid collection and diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Body Fluid Collection And Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the body fluid collection and diagnostics market include Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Illumina Inc, Guardant Health, QIAGEN, Johnson & Johnson, Laboratory Corporation of America Holdings, Biocept Inc, F. Hoffmann-La Roche Ltd., MDxHealth SA. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies